Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of age
- 30 September 2008
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 110 (3) , S11-S17
- https://doi.org/10.1016/j.ygyno.2008.06.029
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseasesVaccine, 2006
- Persistence and load of high‐risk HPV are predictors for development of high‐grade cervical lesions: A longitudinal French cohort studyInternational Journal of Cancer, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up studyBMJ, 2002
- Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial NeoplasiaJAMA, 2001
- Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort studyPublished by Elsevier ,2001
- Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical CancerNew England Journal of Medicine, 1999
- Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective studyThe Lancet, 1999
- Detection of Human Papillomavirus DNA in Cytologically Normal Women and Subsequent Cervical Squamous Intraepithelial LesionsJNCI Journal of the National Cancer Institute, 1999